Publication | Open Access
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma
193
Citations
23
References
2018
Year
Tumor ImmunologyCancer ImmunosurveillanceImproved SurvivalAnti-pd1 ImmunotherapyMedicineMelanomaImmunologyMetastatic MelanomaImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologySkin Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1